The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy.

Author: AtanackovicG, KorenG, MorettiM E, NaviozY

Paper Details 
Original Abstract of the Article :
A delayed-release combination of doxylamine-pyridoxine (D-P) (Diclectin) is the only approved antiemetic medication for use in pregnancy in Canada. The standard recommended dose is up to 4 tablets a day, regardless of body weight or severity of symptoms. The objective of this study was to determine ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/00912700122010735

データ提供:米国国立医学図書館(NLM)

Doxylamine-Pyridoxine (Diclectin) for Nausea and Vomiting of Pregnancy

This research investigates the safety and efficacy of doxylamine-pyridoxine (D-P) (Diclectin), a commonly prescribed antiemetic for nausea and vomiting of pregnancy (NVP). The study, based on a prospective observational design, analyzed the incidence of adverse maternal and fetal effects in women taking Diclectin at both the recommended and higher-than-recommended doses. The researchers meticulously assessed maternal side effects and pregnancy outcomes, including birth weight and gestational age. Their findings suggest that Diclectin can be safely used at doses higher than the standard recommendation, providing valuable insights for managing NVP in pregnant women.

Higher Doses of Diclectin: A Safe and Effective Approach

The study found no association between the dose of Diclectin and the incidence of maternal side effects, suggesting that higher doses can be safely administered. The researchers also observed no adverse effects on pregnancy outcomes, with birth weight and gestational age comparable to those in the general population. These findings provide reassurance for clinicians and pregnant women facing severe NVP.

Navigating the Rollercoaster of Pregnancy

This research provides valuable information for pregnant women and healthcare professionals navigating the challenges of NVP. The study's findings on the safety and efficacy of Diclectin at higher doses offer a valuable tool for managing this common pregnancy complication. It’s like finding a calming oasis in the desert of pregnancy-related nausea.

Dr. Camel's Conclusion

This study provides a reassuring beacon of hope for pregnant women struggling with nausea and vomiting. The findings suggest that Diclectin can be safely administered at higher doses, offering a potent tool for managing this common pregnancy complication. It's like finding a soothing remedy for the desert storms of pregnancy-related nausea.
Date :
  1. Date Completed 2001-12-13
  2. Date Revised 2019-08-26
Further Info :

Pubmed ID

11504271

DOI: Digital Object Identifier

10.1177/00912700122010735

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.